Calculated Tumor Volume Is an Independent Predictor of Biochemical Recurrence in Patients Who Underwent Retropubic Radical Prostatectomy

por Tanaka, Nobumichi, Fujimoto, Kiyohide, Hirayama, Akihide, Nakai, Yasushi, Chihara, Yoshitomo, Anai, Satoshi, Tomioka, Atsushi, Shimada, Keiji, Konishi, Noboru, Hirao, Yoshihiko
Publicado 2012

Novel missense mutation in the FH gene in familial renal cell cancer patients lacking cutaneous leiomyomas

por Kuwada, Masaomi, Chihara, Yoshitomo, Lou, Yi, Torimoto, Kazumasa, Kagebayashi, Yoriaki, Tamura, Kenji, Shuin, Taro, Fujimoto, Kiyohide, Kuniyasu, Hiroki, Samma, Shoji
Publicado 2014

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer

por Tomioka, Atsushi, Tanaka, Nobumichi, Yoshikawa, Motokiyo, Miyake, Makito, Anai, Satoshi, Chihara, Yoshitomo, Okajima, Eijiro, Hirayama, Akihide, Hirao, Yoshihiko, Fujimoto, Kiyohide
Publicado 2014

Photodynamic diagnosis of shed prostate cancer cells in voided urine treated with 5-aminolevulinic acid

por Nakai, Yasushi, Anai, Satoshi, Kuwada, Masaomi, Miyake, Makito, Chihara, Yoshitomo, Tanaka, Nobumichi, Hirayama, Akihide, Yoshida, Katsunori, Hirao, Yoshihiko, Fujimoto, Kiyohide
Publicado 2014

Diagnostic approach for cancer cells in urine sediments by 5-aminolevulinic acid-based photodynamic detection in bladder cancer

por Miyake, Makito, Nakai, Yasushi, Anai, Satoshi, Tatsumi, Yoshihiro, Kuwada, Masaomi, Onishi, Sayuri, Chihara, Yoshitomo, Tanaka, Nobumichi, Hirao, Yoshihiko, Fujimoto, Kiyohide
Publicado en Cancer Sci (2014)

Risk factors of PSA progression and overall survival in patients with localized and locally advanced prostate cancer treated with primary androgen deprivation therapy

por Tomioka, Atsushi, Tanaka, Nobumichi, Yoshikawa, Motokiyo, Miyake, Makito, Anai, Satoshi, Chihara, Yoshitomo, Okajima, Eijiro, Hirayama, Akihide, Hirao, Yoshihiko, Fujimoto, Kiyohide
Publicado en BMC Cancer (2015)

Diagnostic markers of urothelial cancer based on DNA methylation analysis

por Chihara, Yoshitomo, Kanai, Yae, Fujimoto, Hiroyuki, Sugano, Kokichi, Kawashima, Kiyotaka, Liang, Gangning, Jones, Peter A, Fujimoto, Kiyohide, Kuniyasu, Hiroki, Hirao, Yoshihiko
Publicado 2013

Unique DNA methylation patterns distinguish non-invasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue

por Wolff, Erika M., Chihara, Yoshitomo, Pan, Fei, Weisenberger, Daniel J., Siegmund, Kimberly D., Sugano, Kokichi, Kawashima, Kiyotaka, Laird, Peter W., Jones, Peter A., Liang, Gangning
Publicado 2010

Expression of MAS1 in breast cancer

por Luo, Yi, Tanabe, Eriko, Kitayoshi, Misaho, Nishiguchi, Yukiko, Fujiwara, Rina, Matsushima, Sayako, Sasaki, Takamitsu, Sasahira, Tomonori, Chihara, Yoshitomo, Nakae, Dai, Fujii, Kiyomu, Ohmori, Hitoshi, Kuniyasu, Hiroki
Publicado en Cancer Sci (2015)

Reprogramming of the human intestinal epigenome by surgical tissue transposition

por Lay, Fides D., Triche, Timothy J., Tsai, Yvonne C., Su, Sheng-Fang, Martin, Sue Ellen, Daneshmand, Siamak, Skinner, Eila C., Liang, Gangning, Chihara, Yoshitomo, Jones, Peter A.
Publicado 2014

Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples

por Piatti, Paolo, Chew, Yap Ching, Suwoto, Michiko, Yamada, Taikun, Jara, Benjamin, Jia, Xi-Yu, Guo, Wei, Ghodoussipour, Saum, Daneshmand, Siamak, Ahmadi, Hamed, Rice, Jeffrey, Bhasin, Jeffrey, Holloway, Faith, Tsai, Yvonne, Chihara, Yoshitomo, Liang, Gangning
Publicado en Clin Epigenetics (2021)

Diagnostic and prognostic role of urinary collagens in primary human bladder cancer

por Miyake, Makito, Morizawa, Yosuke, Hori, Shunta, Tatsumi, Yoshihiro, Onishi, Sayuri, Owari, Takuya, Iida, Kota, Onishi, Kenta, Gotoh, Daisuke, Nakai, Yasushi, Anai, Satoshi, Chihara, Yoshitomo, Torimoto, Kazumasa, Aoki, Katsuya, Tanaka, Nobumichi, Shimada, Keiji, Konishi, Noboru, Fujimoto, Kiyohide
Publicado en Cancer Sci (2017)